Portage Biotech Q3 EPS $(1.88) Misses $(0.27) Estimate
Portfolio Pulse from Happy Mohamed
Portage Biotech (NASDAQ:PRTG) reported a Q3 EPS loss of $(1.88), significantly missing the analyst consensus estimate of $(0.27) by 596.3%. This represents a 327.27% increase in losses compared to the $(0.44) per share loss reported in the same period last year.
February 28, 2024 | 10:21 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Portage Biotech reported a Q3 EPS loss of $(1.88), missing estimates by 596.3% and marking a significant increase in losses from the previous year.
The substantial miss in earnings per share (EPS) and the significant increase in losses year-over-year are likely to negatively impact investor sentiment and could lead to a decrease in the stock price of Portage Biotech in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100